Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jubilant Life Sciences
Manufacturing
Jubilant HollisterStier Montreal site gets FDA warning letter
Jubilant HollisterStier earned an FDA warning letter after inspectors found its Montreal production plant lacked appropriate quality control systems.
Joseph Keenan
Jun 25, 2026 8:08am
Jubilant HollisterStier to pump $76M into Montreal facility
Jul 14, 2022 9:55am
Jubilant to double injectables work with $146.6M in US funding
May 31, 2022 9:20am
Samsung, Moderna, Brii and more—Fierce Pharma Asia
Aug 27, 2021 9:20am
FDA scolds Jubilant in the first public Form 483 in months
Aug 23, 2021 11:15am
CDMO Jubilant HollisterStier set to boost production capacity
Jun 4, 2021 3:32pm
